If you think that ADE can get PEL 105 drilled in the next 18 months, which they will of course, the options are one of the buys of the bourse atm.Just my opinion of course.Regards,TCG
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%